Latest Industry Updates
From company milestones to industry breakthroughs, uncover the stories making waves and shaping the narrative in real time.
- Press Release
Risk Planning Guidance Addresses FDA, EMA, PMDA and MHRA Coronavirus Advice King of Prussia, PA: CluePoints,...
- Featured Article
Amid the ongoing Coronavirus pandemic, clinical trial sites are increasingly inaccessible for patients and site staff,...
Source: Tufts Center for the Study of Drug Development
- Press Release
We’re delighted to announce that the recording for our COVID-19 webinar has been posted! About the...
- Press Release
Remote monitoring is mitigating the impact of SARS-CoV-2 on clinical trials, marking an acceleration in the...
- Featured Article
The use of direct source data capture in clinical research is on the rise, both during...
Source: Clinical Research News
- Featured Article
The clinical research industry has gone through an important transformation over the past 15 to 20...
Source: ACRP
- Press Release
King of Prussia, PA: CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Risk-Based Quality...
- Featured Article
Poor quality data has the potential to destroy the validity of a clinical trial, wasting precious...
Source: Tufts Center for the Study of Drug Development
- Press Release
KING OF PRUSSIA, PA: CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Data Quality...
- Featured Article
Participant safety is the clinical trial sector’s top priority – and striving to achieve this laudable...
Source: Applied Clinical Trials
- Press Release
KING OF PRUSSIA, PA– FDA and its stakeholders have an interest in assuring the integrity of...
- Featured Article
The latest version of the Good Clinical Practice (GCP) quality standard insists that sponsors implement a...
Source: Global Forum
